Skip to content

Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance

Verification of Performance of Sustained Acoustic Medicine Device Designs Diathermy

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05259995
Enrollment
54
Registered
2022-03-02
Start date
2022-02-21
Completion date
2022-06-30
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measurement of Diathermy on Anatomical Locations of the Body

Brief summary

The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.

Interventions

The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity delivering 18,720 Joules of ultrasound per 4 hour treatment.

Sponsors

ZetrOZ, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

• Healthy Volunteer

Exclusion criteria

* Is pregnant/nursing. * Has an active infection, open sores, or wounds in the treatment area.

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound Diathermy (Degrees Centigrade)0 - 4 hoursTemperature Measurement On Body (Degrees Centigrade)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026